Camilo Velez‐Vega

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Thomas F. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir et al. · Nature Microbiology · 2017 · 271 citations

Life Sciences, Infectious Diseases, Microbiology +16

Rational design of a new antibiotic class for drug-resistant infections

Thomas F. Durand-Réville, Alita A. Miller, John P. O’Donnell et al. · Nature · 2021 · 140 citations

Life Sciences, Infectious Diseases, Medicinal Chemistry +16

Overcoming dissipation in the calculation of standard binding free energies by ligand extraction

Camilo Velez‐Vega, Michael K. Gilson · Journal of Computational Chemistry · 2013 · 65 citations · Full text

Natural Sciences, Chemistry, Physics +17

Evaluating the Efficiency of the Martini Force Field to Study Protein Dimerization in Aqueous and Membrane Environments

Christos Lamprakis, Ioannis Andreadelis, John I. Manchester et al. · Journal of Chemical Theory and Computation · 2021 · 64 citations

Life Sciences, Biochemistry, Biophysics +17

Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease

Ànna Pavlova, Diane L. Lynch, Isabella Daidone et al. · Chemical Science · 2020 · 59 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15